- The trend backdrop is active with a 21-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is constructive, supporting the smart-money activity read.
- Latest weekly return ranks in the strongest part of its sector group.
AKE
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Arkema S.A. · Basic Materials · Specialty Chemicals
Latest close
61.45 EUR
4.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.8% above the Trend Line and sits at 90.3% of its 52-week range. The latest completed week returned 4.3%, after a 12.8% four-week move. The latest news-sentiment score is 57/100. Near-term considerations: price is close to its 52-week high.
Setup score
64
out of 100
Latest Close
61.45 EUR
7 Aug 2026
1W Return
4.3%
latest completed week
4W Return
12.8%
short-term follow-through
12W Return
4.1%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 44.17% based on similar historical setup states.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.3%
Latest completed week; four-week move 12.8%.
Indicator stack
67/40
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.17%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
57/100
17 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.8% above the Trend Line and sits at 90.3% of its 52-week range. The latest completed week returned 4.3%, after a 12.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5912-week average 0.68
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.8% over four weeks, 4.1% over 12 weeks, and 4.6% over one year. The current trend has remained active for 21 consecutive weeks.
Performance by holding period
Active trend streak21 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.28Latest activity-pressure read.
Pressure change-56.7%Four-week change in activity pressure.
Leadership6.48Latest relative-leadership reading.
RS change405.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 17 relevant articles.
6 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.7%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+15.2%Week of 27 Mar.
Worst week-14.9%Week of 6 Mar.
Latest week+4.3%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains10
Flat weeks0
Modest losses7
Sharp losses4
Recent vol3.0%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Basic Materials
4-week rank4 / 31
Group average2.6%
Trend breadth25.8%
Trend25.8%active weekly trend signals
MD38.7%positive activity pressure
RS35.5%positive relative leadership
Four-week leaders
IndustryFR Specialty Chemicals
4-week rank3 / 11
Group average4.7%
Trend breadth27.3%
Trend27.3%active weekly trend signals
MD36.4%positive activity pressure
RS45.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis71/100Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 9/12.
Activity pressure 0.59; No reversal markers Next-Week ExpectancyNegative 44.17%Next-week expectancy is negative with a 44.17% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 17 relevant articles.
Arkema (ENXTPA:AKE) Stock Reprices A Margin Recovery Story Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 61.45 EUR | 4.3% | 55.95 EUR | 66.69 EUR | -0.28 | 6.48 | 884.4K | On |
| 31 Jul 2026 | 58.90 EUR | 5.6% | 55.58 EUR | 66.83 EUR | -0.55 | 4.36 | 1.1M | On |
| 24 Jul 2026 | 55.80 EUR | 0.1% | 55.26 EUR | 66.98 EUR | -0.73 | 0.40 | 907.1K | On |
| 17 Jul 2026 | 55.75 EUR | 2.3% | 55.00 EUR | 67.17 EUR | -0.55 | 0.38 | 825.3K | On |
| 10 Jul 2026 | 54.50 EUR | -3.7% | 54.76 EUR | 67.32 EUR | -0.18 | -2.12 | 1.1M | On |
| 3 Jul 2026 | 56.60 EUR | 1.0% | 54.61 EUR | 67.47 EUR | 0.20 | -0.69 | 155.3K | On |
| 26 Jun 2026 | 56.05 EUR | -3.5% | 54.34 EUR | 67.60 EUR | 0.51 | -0.48 | 161.2K | On |
| 19 Jun 2026 | 58.10 EUR | 1.2% | 54.12 EUR | 67.71 EUR | 0.74 | 2.35 | 265.4K | On |
| 12 Jun 2026 | 57.40 EUR | -4.4% | 53.78 EUR | 67.78 EUR | 0.68 | 1.83 | 267.7K | On |
| 5 Jun 2026 | 60.05 EUR | -1.4% | 53.50 EUR | 67.88 EUR | 0.60 | 8.09 | 176.2K | On |
| 29 May 2026 | 60.90 EUR | 3.9% | 53.12 EUR | 67.95 EUR | 0.71 | 10.10 | 1.1M | On |
| 22 May 2026 | 58.60 EUR | -0.7% | 52.70 EUR | 68.03 EUR | 0.66 | 6.76 | 1.4M | On |
| 15 May 2026 | 59.02 EUR | -0.6% | 52.42 EUR | 68.13 EUR | 0.71 | 9.65 | 938.9K | On |
| 8 May 2026 | 59.40 EUR | 1.7% | 52.08 EUR | 68.23 EUR | 0.80 | 8.12 | 1.6M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.